Apellis Pharmaceuticals I...

NASDAQ: APLS · Real-Time Price · USD
20.63
0.55 (2.74%)
At close: May 02, 2025, 1:57 PM

13F Institute Ownership

Total Institutes of 283 in Apellis Pharmaceuticals reduced their positions with a decrease of 9 investors compared to the previous quarter. An additional 9.64M shares, as total invested capital grew by $668.07M with ownership percentage increasing from 94.49% to 102.27%.

Options Activity

Institutions are holding more Calls Contracts as Puts Contracts, indicating a bullish sentiment.
Put/Call 0.320
0.32
Call Flow 2,621,100
76%
Put Flow 839,500
24%

Top Shareholders

Institute Ownership Shares Shares % Change Market Value Portfolio
Avoro Capital Advisors LLC 9.86% 12.22M +10.00% 390.01M 5.52%
Ecor1 Capital, LLC 9.60% 11.89M +0.00% 379.44M 14.35%
Wellington Management Group Ll... 9.52% 11.8M -24.19% 376.57M 0.07%

Stop Guessing, Start Knowing.

Cut through market noise with actionable insights that actually help you make confident investment decisions. No more endless research or gut-based guessing.

Unlimited access to all data and tools
Unlimited access to all data and tools, giving you the edge over everyone else in the market.
Realtime Options & Dark Pool Data
Instant access to live options & dark pool data to spot opportunities and trade with precision before the market moves.
Top Wallstreet Analyst Ratings
Follow ratings from the best analysts on Wall Street to stay ahead.
Up to 30 years financial history
We deliver premium Wall Street data with top-tier accuracy and up to 30 years of history.